Avanos Medical Inc (AVNS) Shares Sold by Captrust Financial Advisors

Share on StockTwits

Captrust Financial Advisors trimmed its holdings in Avanos Medical Inc (NYSE:AVNS) by 18.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,226 shares of the company’s stock after selling 279 shares during the quarter. Captrust Financial Advisors’ holdings in Avanos Medical were worth $55,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. California State Teachers Retirement System boosted its holdings in shares of Avanos Medical by 2.3% in the 4th quarter. California State Teachers Retirement System now owns 73,385 shares of the company’s stock valued at $3,287,000 after buying an additional 1,656 shares during the last quarter. United Services Automobile Association boosted its holdings in shares of Avanos Medical by 10.9% in the 4th quarter. United Services Automobile Association now owns 11,456 shares of the company’s stock valued at $513,000 after buying an additional 1,129 shares during the last quarter. Hsbc Holdings PLC boosted its holdings in shares of Avanos Medical by 12.3% in the 4th quarter. Hsbc Holdings PLC now owns 14,827 shares of the company’s stock valued at $664,000 after buying an additional 1,626 shares during the last quarter. Great West Life Assurance Co. Can boosted its holdings in shares of Avanos Medical by 9.8% in the 4th quarter. Great West Life Assurance Co. Can now owns 28,471 shares of the company’s stock valued at $1,182,000 after buying an additional 2,542 shares during the last quarter. Finally, Citigroup Inc. boosted its holdings in shares of Avanos Medical by 45.4% in the 4th quarter. Citigroup Inc. now owns 18,357 shares of the company’s stock valued at $822,000 after buying an additional 5,733 shares during the last quarter. 91.13% of the stock is owned by institutional investors and hedge funds.

NYSE AVNS opened at $42.75 on Wednesday. The company has a market capitalization of $2.04 billion, a PE ratio of 52.13 and a beta of 1.47. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.70 and a quick ratio of 2.24. Avanos Medical Inc has a 12 month low of $38.00 and a 12 month high of $72.96.

Avanos Medical (NYSE:AVNS) last posted its quarterly earnings results on Tuesday, February 26th. The company reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.09. Avanos Medical had a return on equity of 7.20% and a net margin of 8.81%. The business had revenue of $169.90 million for the quarter, compared to analysts’ expectations of $166.88 million. During the same quarter in the prior year, the business earned $0.73 EPS. The firm’s revenue for the quarter was up 2.2% on a year-over-year basis. On average, sell-side analysts forecast that Avanos Medical Inc will post 1.25 earnings per share for the current year.

Several equities research analysts have recently commented on the company. Zacks Investment Research downgraded Avanos Medical from a “hold” rating to a “sell” rating in a report on Tuesday, March 12th. ValuEngine downgraded Avanos Medical from a “buy” rating to a “hold” rating in a report on Monday, March 11th. KeyCorp cut their price objective on Avanos Medical from $67.00 to $65.00 and set an “overweight” rating for the company in a report on Wednesday, February 27th. Finally, Barclays downgraded Avanos Medical from an “equal weight” rating to an “underweight” rating in a report on Friday, January 4th. Three analysts have rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $66.75.

WARNING: This piece was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.tickerreport.com/banking-finance/4234557/avanos-medical-inc-avns-shares-sold-by-captrust-financial-advisors.html.

Avanos Medical Profile

Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.

Recommended Story: The risks of owning bonds

Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical Inc (NYSE:AVNS).

Institutional Ownership by Quarter for Avanos Medical (NYSE:AVNS)

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Unum Group Sees Unusually High Options Volume
Unum Group Sees Unusually High Options Volume
Cap-XX  Shares Up 11.7%
Cap-XX Shares Up 11.7%
Cree  Reaches New 1-Year High at $67.20
Cree Reaches New 1-Year High at $67.20
zooplus  PT Set at €205.00 by JPMorgan Chase & Co.
zooplus PT Set at €205.00 by JPMorgan Chase & Co.
RWS  PT Raised to GBX 615 at Berenberg Bank
RWS PT Raised to GBX 615 at Berenberg Bank
ASGN  Research Coverage Started at Royal Bank of Canada
ASGN Research Coverage Started at Royal Bank of Canada


© 2006-2019 Ticker Report